Ching Ming, Maxey Chung

Chung Ching Ming, Maxey

Appointment(s)
  • Associate Professor, Department of Biochemistry
Administrative Appointment(s)
  • Deputy Head, Department of Biochemistry
Academic Qualifications
  • PhD, Victoria University of Wellington, New Zealand
  • MSc (Hons, First Class), Victoria University Of Wellington, New Zealand
  • BSc, Victoria University of Wellington, New Zealand
Research Interest(s)
  • Proteomics
  • Liver
  • Gastric and Colorectal Cancers
  • Biomarkers Discovery
  • Protein Structure and Function
Recent Publications
  • 1. Lin Q, Lim HS, Lin HL, Tan HT, Lim TK, Cheong WK3, Cheah PY, Tang CL, Chow PK, Chung MC. 2015 Nov. Analysis of colorectal cancer glyco-secretome identifies laminin β-1 (LAMB1) as a potential serological biomarker for colorectal cancer. Proteomics. 15(22):3905-20. doi: 10.1002/pmic.201500236. 26359947.
  • 2. Tan HT, Lim TK, Richards AM, Kofidis T, Teoh KL, Ling LH, Chung MC. 2015 Sep. Unravelling the proteome of degenerative human mitral valves. Proteomics. 15(17):2934-44. doi: 10.1002/pmic.201500040.25914152.
  • 3. Ong CW, Chong PY, McArt DG, Chan JY, Tan HT, Kumar AP, Chung MC, Clément MV, Soong R, Van Schaeybroeck S, Waugh DJ, Johnston PG, Dunne PD, Salto-Tellez M. 2015 May. The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers. Oncotarget. 6(14):12763-73. doi: 10.18632/oncotarget.3497. 25906747.
  • 4. Wu W, Tan XF, Tan HT, Lim TK, Chung MC. 2014 Dec. Unbiased proteomic and transcript analyses reveal that stathmin-1 silencing inhibits colorectal cancer metastasis and sensitizes to 5-fluorouracil treatment. Mol Cancer Res. 12(12):1717-28. doi: 10.1158/1541-7786.MCR-14-0088-T. 25063586.
  • 5. Tan GS, Lim KH, Tan HT, Khoo ML, Tan SH, Toh HC, Ching Ming Chung M. 2014 Nov. Novel proteomic biomarker panel for prediction of aggressive metastatic hepatocellular carcinoma relapse in surgically resectable patients. J Proteome Res. 13(11):4833-46. doi: 10.1021/pr500229n. 24946162.